Literature DB >> 20943311

miRNAs in the pathogenesis of oncogenic human viruses.

Zhen Lin1, Erik K Flemington.   

Abstract

Tumor viruses are a class of pathogens with well established roles in the development of malignant diseases. Numerous bodies of work have highlighted miRNAs (microRNAs) as critical regulators of tumor pathways and it is clear that the dysregulation of cellular miRNA expression can promote tumor formation. Tumor viruses encode their own miRNAs and/or manipulate the expression of cellular miRNAs to modulate their host cell environment, thereby facilitating their respective infection cycles. The modulation of these miRNA responsive pathways, however, often influences certain signal transduction cascades in ways that favor tumorigenesis. In this review, we discuss the roles of virally-encoded and virally-regulated cellular miRNAs in the respective viral life cycles and in virus associated pathogenesis.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943311      PMCID: PMC3023823          DOI: 10.1016/j.canlet.2010.08.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  169 in total

1.  A skin microRNA promotes differentiation by repressing 'stemness'.

Authors:  Rui Yi; Matthew N Poy; Markus Stoffel; Elaine Fuchs
Journal:  Nature       Date:  2008-03-02       Impact factor: 49.962

2.  Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.

Authors:  Natalie Motsch; Thorsten Pfuhl; Jan Mrazek; Stephanie Barth; Friedrich A Grässer
Journal:  RNA Biol       Date:  2007-11       Impact factor: 4.652

3.  Loss of mir-146a function in hormone-refractory prostate cancer.

Authors:  Shi-Lung Lin; Angela Chiang; Donald Chang; Shao-Yao Ying
Journal:  RNA       Date:  2008-01-03       Impact factor: 4.942

4.  Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency.

Authors:  Eain Murphy; Jirí Vanícek; Harlan Robins; Thomas Shenk; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

5.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Authors:  I Martinez; A S Gardiner; K F Board; F A Monzon; R P Edwards; S A Khan
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

6.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

7.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Authors:  I A Asangani; S A K Rasheed; D A Nikolova; J H Leupold; N H Colburn; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

8.  EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

Authors:  Tianli Xia; Andrea O'Hara; Iguaracyra Araujo; Jose Barreto; Eny Carvalho; Jose Bahia Sapucaia; Juan Carlos Ramos; Estela Luz; Celia Pedroso; Michele Manrique; Ngoc L Toomey; Carlos Brites; Dirk P Dittmer; William J Harrington
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

9.  MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.

Authors:  Yongxiu Yao; Yuguang Zhao; Hongtao Xu; Lorraine P Smith; Charles H Lawrie; Michael Watson; Venugopal Nair
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

10.  Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element.

Authors:  Dominique L Ouellet; Isabelle Plante; Patricia Landry; Corinne Barat; Marie-Eve Janelle; Louis Flamand; Michel J Tremblay; Patrick Provost
Journal:  Nucleic Acids Res       Date:  2008-02-24       Impact factor: 16.971

View more
  26 in total

1.  Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells.

Authors:  Ling Wang; Shunbin Ning
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

Review 2.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

Review 3.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

4.  Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

Authors:  Xiaojie Xu; Zhongyi Fan; Lei Kang; Juqiang Han; Chengying Jiang; Xiaofei Zheng; Ziman Zhu; Huabo Jiao; Jing Lin; Kai Jiang; Lihua Ding; Hao Zhang; Long Cheng; Hanjiang Fu; Yi Song; Ying Jiang; Jiahong Liu; Rongfu Wang; Nan Du; Qinong Ye
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 5.  Complex interactions between microRNAs and hepatitis B/C viruses.

Authors:  Hong-Xia Fan; Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 6.  The miRNAs of herpes simplex virus (HSV).

Authors:  Le Sun; Qihan Li
Journal:  Virol Sin       Date:  2012-11-09       Impact factor: 4.327

7.  Prediction of disease-related interactions between microRNAs and environmental factors based on a semi-supervised classifier.

Authors:  Xing Chen; Ming-Xi Liu; Qing-Hua Cui; Gui-Ying Yan
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 8.  Pathogenic Role of Epstein-Barr Virus in Lung Cancers.

Authors:  David Becnel; Ramsy Abdelghani; Asuka Nanbo; Janardhan Avilala; Jacob Kahn; Li Li; Zhen Lin
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

9.  miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells.

Authors:  Lin Fang; Hai-Bing Zhang; Hua Li; Yong Fu; Guang-Shun Yang
Journal:  Radiol Oncol       Date:  2012-04-11       Impact factor: 2.991

10.  MicroRNAs Involved in Anti-Tumour Immunity.

Authors:  Hong W H Yu; Daniel M Y Sze; William C S Cho
Journal:  Int J Mol Sci       Date:  2013-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.